why Amylyx Pharmaceuticals Inc [AMLX] is a Good Choice for Investors After New Price Target of $4.25
Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] traded at a low on Thursday, posting a -5.32 loss after which it closed the day’ session at $1.78. The results of the trading session contributed to over 2476759 shares changing hands. Over the past one week, the price volatility